Nalaganje...
Amelioration of deficit syndrome of schizophrenia by norepinephrine reuptake inhibitor
OBJECTIVE: Negative symptoms are a significant barrier to successful functional outcome and recovery in individuals with schizophrenia and their management is not unproblematic. Reboxetine is a norepinephrine reuptake inhibitor (NRI). Previous studies regarding the useful effects of reboxetine on de...
Shranjeno v:
| izdano v: | Ther Adv Psychopharmacol |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
SAGE Publications
2015
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4622119/ https://ncbi.nlm.nih.gov/pubmed/26557982 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2045125315591953 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|